First reported case of safe and efficacious use of tocilizumab for treatment of hyperinflammatory syndrome associated with COVID‐19 in an allogeneic stem cell transplant patient

Detalles Bibliográficos
Autores principales: Fordham, Nicholas, Baker, Emma, Forton, Daniel, Klammer, Matthias, Patel, Kamal, Qadir, Dara, Reyal, Yasmin, Willis, Fenella, Koh, Mickey B.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175733/
https://www.ncbi.nlm.nih.gov/pubmed/35846103
http://dx.doi.org/10.1002/jha2.132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175733/
https://www.ncbi.nlm.nih.gov/pubmed/35846103
http://dx.doi.org/10.1002/jha2.132

Ejemplares similares